Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deirdre A Lane

Showing results (1-10 of 347) with videos related to

Pageof 35
Sort By:
Heart (British Cardiac Society)|July 16, 2020
Homelessness: a 'cause of the causes' of cardiovascular disease?Deirdre A Lane
Thrombosis and Haemostasis|July 3, 2018
Use of NOACs in the Peri-Operative Management of Patients with Atrial Fibrillation: To Stop, Bridge or Continue?Marco Proietti, Deirdre A Lane
Thrombosis and Haemostasis|March 6, 2020
The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients: A Systematic Need for New StrategiesMarco Proietti, Deirdre A Lane
Circulation|April 23, 2015
Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillationDeirdre A Lane, Kathryn Wood
Thrombosis and Haemostasis|October 30, 2020
Patient Satisfaction: A Key Component in Increasing Treatment Adherence and PersistenceElena Ivany, Deirdre A Lane
Heart Rhythm|October 17, 2012
To the Editor - Adding renal dysfunction to CHA₂DS₂-VASc improves stroke prediction postcatheter ablationDeirdre A Lane, Amitava Banerjee
Journal of Hypertension|November 7, 2007
Amiloride 10 mg is less effective than spironolactone 25 mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agentDeirdre A Lane, D Gareth Beevers
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2005
Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the 'real world' and the need for risk stratificationDeirdre A Lane, Gregory Yh Lip
Circulation Journal : Official Journal of the Japanese Circulation Society|July 11, 2014
Modern management of atrial fibrillation requires initial identification of "low-risk" patients using the CHA2DS2-VASc score, and not focusing on "high-risk" predictionGregory Yh Lip, Deirdre A Lane
The Cochrane Database of Systematic Reviews|October 13, 2009
Treatment of hypertension in peripheral arterial diseaseDeirdre A Lane, Gregory Yh Lip
Pageof 35

Showing results (1-10 of 347) with videos related to

Sort By:
Pageof 35
Heart (British Cardiac Society)|July 16, 2020
Homelessness: a 'cause of the causes' of cardiovascular disease?Deirdre A Lane
Thrombosis and Haemostasis|July 3, 2018
Use of NOACs in the Peri-Operative Management of Patients with Atrial Fibrillation: To Stop, Bridge or Continue?Marco Proietti, Deirdre A Lane
Thrombosis and Haemostasis|March 6, 2020
The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients: A Systematic Need for New StrategiesMarco Proietti, Deirdre A Lane
Circulation|April 23, 2015
Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillationDeirdre A Lane, Kathryn Wood
Thrombosis and Haemostasis|October 30, 2020
Patient Satisfaction: A Key Component in Increasing Treatment Adherence and PersistenceElena Ivany, Deirdre A Lane
Heart Rhythm|October 17, 2012
To the Editor - Adding renal dysfunction to CHA₂DS₂-VASc improves stroke prediction postcatheter ablationDeirdre A Lane, Amitava Banerjee
Journal of Hypertension|November 7, 2007
Amiloride 10 mg is less effective than spironolactone 25 mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agentDeirdre A Lane, D Gareth Beevers
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2005
Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the 'real world' and the need for risk stratificationDeirdre A Lane, Gregory Yh Lip
Circulation Journal : Official Journal of the Japanese Circulation Society|July 11, 2014
Modern management of atrial fibrillation requires initial identification of "low-risk" patients using the CHA2DS2-VASc score, and not focusing on "high-risk" predictionGregory Yh Lip, Deirdre A Lane
The Cochrane Database of Systematic Reviews|October 13, 2009
Treatment of hypertension in peripheral arterial diseaseDeirdre A Lane, Gregory Yh Lip
Pageof 35